145 related articles for article (PubMed ID: 32631271)
21. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.
Surapaneni SK; Bhat ZR; Tikoo K
Sci Rep; 2020 Oct; 10(1):17954. PubMed ID: 33087811
[TBL] [Abstract][Full Text] [Related]
24. miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancer.
Liu X; Wang J; Zhang G
J Cell Biochem; 2019 Aug; 120(8):12943-12948. PubMed ID: 30873664
[TBL] [Abstract][Full Text] [Related]
25. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
26. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
Yu Z; Wang C; Wang M; Li Z; Casimiro MC; Liu M; Wu K; Whittle J; Ju X; Hyslop T; McCue P; Pestell RG
J Cell Biol; 2008 Aug; 182(3):509-17. PubMed ID: 18695042
[TBL] [Abstract][Full Text] [Related]
27. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
[TBL] [Abstract][Full Text] [Related]
28. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
[TBL] [Abstract][Full Text] [Related]
29. Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.
Tsai KW; Leung CM; Lo YH; Chen TW; Chan WC; Yu SY; Tu YT; Lam HC; Li SC; Ger LP; Liu WS; Chang HT
Sci Rep; 2016 Jun; 6():28176. PubMed ID: 27307030
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
Jiang S; Zhang HW; Lu MH; He XH; Li Y; Gu H; Liu MF; Wang ED
Cancer Res; 2010 Apr; 70(8):3119-27. PubMed ID: 20354188
[TBL] [Abstract][Full Text] [Related]
31. MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
Long J; Ou C; Xia H; Zhu Y; Liu D
Tumour Biol; 2015 Nov; 36(11):8697-702. PubMed ID: 26047605
[TBL] [Abstract][Full Text] [Related]
32. Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
Wu S; Yu W; Qu X; Wang R; Xu J; Zhang Q; Xu J; Li J; Chen L
J Hematol Oncol; 2014 May; 7():40. PubMed ID: 24886719
[TBL] [Abstract][Full Text] [Related]
33. Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27
Chen Y; Du M; Yusuying S; Liu W; Tan Y; Xie P
Exp Cell Res; 2020 Jul; 392(2):112038. PubMed ID: 32360865
[TBL] [Abstract][Full Text] [Related]
34. miR-129-5p suppresses breast cancer proliferation by targeting CBX4.
Meng R; Fang J; Yu Y; Hou LK; Chi JR; Chen AX; Zhao Y; Cao XC
Neoplasma; 2018; 65(4):572-578. PubMed ID: 29940764
[TBL] [Abstract][Full Text] [Related]
35. miRNA-dependent regulation of STIM1 expression in breast cancer.
Kulkarni RP; Elmi A; Alcantara-Adap E; Hubrack S; Nader N; Yu F; Dib M; Ramachandran V; Najafi Shoushtari H; Machaca K
Sci Rep; 2019 Sep; 9(1):13076. PubMed ID: 31506588
[TBL] [Abstract][Full Text] [Related]
36. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
37. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
40. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.
Seviour EG; Sehgal V; Lu Y; Luo Z; Moss T; Zhang F; Hill SM; Liu W; Maiti SN; Cooper L; Azencot R; Lopez-Berestein G; Rodriguez-Aguayo C; Roopaimoole R; Pecot CV; Sood AK; Mukherjee S; Gray JW; Mills GB; Ram PT
Oncogene; 2016 Feb; 35(6):691-701. PubMed ID: 25639871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
